Singapore-based medtech firm Aevice Health has secured regulatory approval from the Therapeutic Goods Administration (TGA) to supply its AeviceMD respiratory monitoring system in Australia. Listed as a "thoracic acoustic recorder," the wearable device utilizes software-driven pattern detection to monitor chest sounds and detect wheezing. By leveraging the Comparable Overseas Regulator pathway via Singapore’s Health Sciences Authority, the system has transitioned into the Australian market to support remote patient monitoring and clinical review for chronic respiratory conditions.